My major problem with what I read of Geier's papers is that their approach relied on the same trickery as using statins to reduce cholesterol measurements (based on the belief this may reduce heart disease incidence). . Testosterone levels are not a disease, they are a marker. Their idea was "mess with the marker and MAYBE this affects the disease." To me this logic is exactly the same as using white face makeup to alter the redness of a face, in the hope that reducing the redness will affect the physical condition causing the redness.